About: Associations with covid-19 hospitalisation amongst 406,793 adults: the UK Biobank prospective cohort study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Associations with covid-19 hospitalisation amongst 406,793 adults: the UK Biobank prospective cohort study Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Associations with covid-19 hospitalisation amongst 406,793 adults: the UK Biobank prospective cohort study
Creator	Hysi, Pirro Dick, Andrew Foster, Paul Kastner, Alan Khaw, Kay-Tee Khaw, Peng Khawaja, Anthony Tufail, Adnan Warwick, Alasdair
source	MedRxiv
abstract	OBJECTIVES: To identify the sociodemographic, lifestyle, comorbidity and antihypertensive medication associations with the development of hospitalisation with covid-19 in an English population. DESIGN: Prospective cohort study SETTING: The population-based UK Biobank study was linked to English covid-19 test results. PARTICIPANTS: Individuals resident in England and alive in 2020. MAIN OUTCOME MEASURES: Cases (n=605) were defined by a positive covid-19 test result conducted between 16th March and 16th April 2020, during a restricted testing policy for hospitalised individuals with severe disease. RESULTS: A total of 406,793 participants were included. Mean age on 1st January 2020 was 68 years (range 48 to 85 years). 55% were women. In multivariable models, major independent risk factors for hospitalisation with covid-19 were male sex (odds ratio 1.52; 95% confidence interval 1.28 to 1.81; P<0.001), South Asian ethnicity (2.02; 1.28 to 3.17; P=0.002) or black ethnicity (3.09; 2.18 to 4.38; P<0.001) compared to white ethnicity, greater residential deprivation (1.92 for most deprived quartile compared to least deprived quartile; 1.50 to 2.47; P<0.001), higher BMI (2.04 for BMI >35 compared to <25 Kg/m2; 1.50 to 2.77; P<0.001), former smoking (1.39 compared to never smoked; 1.16 to 1.66; P<0.001), and comorbidities hypertension (1.28; 1.06 to 1.53; P=0.009) and chronic obstructive pulmonary disease (1.81; 1.34 to 2.44; P<0.001). Increased risk was observed with increasing number of antihypertensive medications used rather than any individual class. CONCLUSION: Understanding why these factors confer increased risk of severe covid-19 in the population may help elucidate the underlying mechanisms as well as inform strategy and policy to prevent this disease and its consequences. We found no evidence of increased risk with specific classes of antihypertensive medication.
has issue date	2020-05-11(xsd:dateTime)
bibo:doi	10.1101/2020.05.06.20092957
has license	medrxiv
sha1sum (hex)	72cbad6d88a5832316e413b2e75d617094ed4fb3
schema:url	https://doi.org/10.1101/2020.05.06.20092957
resource representing a document's title	Associations with covid-19 hospitalisation amongst 406,793 adults: the UK Biobank prospective cohort study
resource representing a document's body	covid:72cbad6d88a5832316e413b2e75d617094ed4fb3#body_text
is schema:about of	named entity 'English' named entity 'adults' named entity 'UK Biobank' named entity 'comorbidity' named entity '1, 2' named entity 'socioeconomic' named entity 'ethnicity' named entity 'hypertension' named entity 'risk factor' named entity 'socioeconomic' named entity 'BMI' named entity 'coronavirus disease 2019' named entity 'covid-19' named entity 'antihypertensive medication' named entity 'BMI' named entity 'BMI' named entity 'medRxiv' named entity 'peer review' named entity 'medRxiv' named entity 'covid-19' named entity 'COPD' named entity 'stroke' named entity 'Caribbean' named entity 'ARBs' named entity 'risk factors' named entity 'peer review' named entity 'risk factor' named entity 'covid-19' named entity 'ethnicity' named entity 'risk factors' named entity 'antihypertensive medication' named entity 'covid-19' named entity 'antihypertensives' named entity 'sensitivity analysis' named entity 'assessment centre' named entity 'nutrition' named entity 'antihypertensives' named entity 'standard deviation' named entity 'dose response' named entity 'infection' named entity 'study protocols' named entity 'comorbidities' named entity 'covid-19' named entity 'peer review' named entity 'SARS' named entity 'cohort study' named entity 'asthma' named entity 'covid-19' named entity 'covid-19' named entity 'hypertension' named entity 'infection' named entity 'infection' named entity 'ACE2' named entity 'obese people' named entity 'medRxiv' named entity 'comorbidities' named entity 'diastolic blood pressure' named entity 'risk factors' named entity 'BMI' named entity 'covid-19' named entity 'false negatives' named entity 'socioeconomic' named entity 'infection' named entity 'smokers' named entity 'enzyme' named entity 'ACE inhibitors' named entity 'infection' named entity 'Townsend deprivation index' named entity 'P-values' named entity 'antihypertensive medication' named entity 'covid-19' named entity 'covid-19' named entity 'socioeconomic' named entity 'smokers' named entity 'hypertension' named entity 'Black ethnic groups' named entity 'ACE2'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software